211 related articles for article (PubMed ID: 30786886)
1. DMO-CAP inhibits influenza virus replication by activating heme oxygenase-1-mediated IFN response.
Zhong M; Wang H; Ma L; Yan H; Wu S; Gu Z; Li Y
Virol J; 2019 Feb; 16(1):21. PubMed ID: 30786886
[TBL] [Abstract][Full Text] [Related]
2. Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway.
Yan H; Wang H; Ma L; Ma X; Yin J; Wu S; Huang H; Li Y
Virol J; 2018 May; 15(1):88. PubMed ID: 29783993
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of curcumin on influenza A virus infection and influenzal pneumonia via oxidative stress, TLR2/4, p38/JNK MAPK and NF-κB pathways.
Dai J; Gu L; Su Y; Wang Q; Zhao Y; Chen X; Deng H; Li W; Wang G; Li K
Int Immunopharmacol; 2018 Jan; 54():177-187. PubMed ID: 29153953
[TBL] [Abstract][Full Text] [Related]
4. Rupestonic acid derivative YZH-106 suppresses influenza virus replication by activation of heme oxygenase-1-mediated interferon response.
Ma LL; Wang HQ; Wu P; Hu J; Yin JQ; Wu S; Ge M; Sun WF; Zhao JY; Aisa HA; Li YH; Jiang JD
Free Radic Biol Med; 2016 Jul; 96():347-61. PubMed ID: 27107768
[TBL] [Abstract][Full Text] [Related]
5. heme oxygenase-1 agonist CoPP suppresses influenza virus replication through IRF3-mediated generation of IFN-α/β.
Ma LL; Zhang P; Wang HQ; Li YF; Hu J; Jiang JD; Li YH
Virology; 2019 Feb; 528():80-88. PubMed ID: 30580124
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of JIP4 at S730 Presents Antiviral Properties against Influenza A Virus Infection.
Del Sarto J; Gerlt V; Friedrich ME; Anhlan D; Wixler V; Teixeira MM; Boergeling Y; Ludwig S
J Virol; 2021 Sep; 95(20):e0067221. PubMed ID: 34319782
[TBL] [Abstract][Full Text] [Related]
7. Aurantiamide acetate from baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-κB signaling pathway in Influenza A virus-infected cells.
Zhou B; Yang Z; Feng Q; Liang X; Li J; Zanin M; Jiang Z; Zhong N
J Ethnopharmacol; 2017 Mar; 199():60-67. PubMed ID: 28119097
[TBL] [Abstract][Full Text] [Related]
8. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
[TBL] [Abstract][Full Text] [Related]
9. Sinensetin suppresses influenza a virus-triggered inflammation through inhibition of NF-κB and MAPKs signalings.
Li J; Jie X; Liang X; Chen Z; Xie P; Pan X; Zhou B; Li J
BMC Complement Med Ther; 2020 May; 20(1):135. PubMed ID: 32370749
[TBL] [Abstract][Full Text] [Related]
10. Emodin Inhibition of Influenza A Virus Replication and Influenza Viral Pneumonia via the Nrf2, TLR4, p38/JNK and NF-kappaB Pathways.
Dai JP; Wang QW; Su Y; Gu LM; Zhao Y; Chen XX; Chen C; Li WZ; Wang GF; Li KS
Molecules; 2017 Oct; 22(10):. PubMed ID: 29057806
[TBL] [Abstract][Full Text] [Related]
11. Inhibition effects of novel polyketide compound PPQ-B against influenza A virus replication by interfering with the cellular EGFR pathway.
Wang M; Wang S; Wang W; Wang Y; Wang H; Zhu W
Antiviral Res; 2017 Jul; 143():74-84. PubMed ID: 28414053
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation.
Liu G; Lu Y; Liu Q; Zhou Y
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602605
[TBL] [Abstract][Full Text] [Related]
13. A dual character of flavonoids in influenza A virus replication and spread through modulating cell-autonomous immunity by MAPK signaling pathways.
Dong W; Wei X; Zhang F; Hao J; Huang F; Zhang C; Liang W
Sci Rep; 2014 Nov; 4():7237. PubMed ID: 25429875
[TBL] [Abstract][Full Text] [Related]
14. Protein Tyrosine Phosphatase SHP2 Suppresses Host Innate Immunity against Influenza A Virus by Regulating EGFR-Mediated Signaling.
Wang Q; Pan W; Wang S; Pan C; Ning H; Huang S; Chiu SH; Chen JL
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361428
[TBL] [Abstract][Full Text] [Related]
15. Anti-influenza A virus activity of rhein through regulating oxidative stress, TLR4, Akt, MAPK, and NF-κB signal pathways.
Wang QW; Su Y; Sheng JT; Gu LM; Zhao Y; Chen XX; Chen C; Li WZ; Li KS; Dai JP
PLoS One; 2018; 13(1):e0191793. PubMed ID: 29385192
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of aloe-emodin against influenza A virus via galectin-3 up-regulation.
Li SW; Yang TC; Lai CC; Huang SH; Liao JM; Wan L; Lin YJ; Lin CW
Eur J Pharmacol; 2014 Sep; 738():125-32. PubMed ID: 24877694
[TBL] [Abstract][Full Text] [Related]
17. Cappariloside A shows antiviral and better anti-inflammatory effects against influenza virus via regulating host IFN signaling, in vitro and vivo.
Li Z; Zhao J; Zhou H; Li L; Ding Y; Li J; Zhou B; Jiang H; Zhong N; Hu W; Yang Z
Life Sci; 2018 May; 200():115-125. PubMed ID: 29555588
[TBL] [Abstract][Full Text] [Related]
18. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
[TBL] [Abstract][Full Text] [Related]
19. Type-IInterferon-Inducible SERTAD3 Inhibits Influenza A Virus Replication by Blocking the Assembly of Viral RNA Polymerase Complex.
Sun N; Li C; Li XF; Deng YQ; Jiang T; Zhang NN; Zu S; Zhang RR; Li L; Chen X; Liu P; Gold S; Lu N; Du P; Wang J; Qin CF; Cheng G
Cell Rep; 2020 Nov; 33(5):108342. PubMed ID: 33147462
[TBL] [Abstract][Full Text] [Related]
20. Santin inhibits influenza A virus replication through regulating MAPKs and NF-κB pathways.
Zhong M; Wang HQ; Yan HY; Wu S; Gu ZY; Li YH
J Asian Nat Prod Res; 2019 Dec; 21(12):1205-1214. PubMed ID: 30417663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
